Todd Alea
Physical Medicine and Rehabilitation · Homestead, FLNPI 1780676791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Almatica Pharma LLC at 31.9% of the total. Reporting peaked in 2021 at $82 and has fallen 75.4% since, to $20 in 2024. That places this record below the midpoint for physical medicine and rehabilitation clinicians in FL, where the typical reported total is $200.
Across 9 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Almatica Pharma LLC$59
- Kowa Pharmaceuticals America, Inc.$34
- IBSA Pharma Inc.$23
- Amgen$23
- Electronic Waveform Lab, Inc.$20
- Pfizer$16
- plus $10 from 1 others
What the payments were for
- Food & beverage$185100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Almatica Pharma LLC | 2 | $59 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| IBSA Pharma Inc. | 1 | $23 |
| Amgen | 1 | $23 |
| Electronic Waveform Lab, Inc. | 1 | $20 |
| Pfizer | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $10 |
How this compares
$185 in reported general payments places this provider in the 45th percentile of 618 physical medicine and rehabilitation providers in Florida.
See all physical medicine and rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Morphine Sulfate ErMorphine Sulfate | 42 | $1,607 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $1,253 |
| Naloxone Hcl | 12 | $1,163 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $791 |
| Diclofenac Sodium | 21 | $780 |
| Gabapentin | 62 | $547 |
| Hydromorphone Hcl | 15 | $385 |
| Meloxicam | 86 | $326 |
| Cyclobenzaprine Hcl | 44 | $269 |
| Tramadol Hcl | 49 | $218 |
| Lorazepam | 12 | $162 |
| Pregabalin | 12 | $113 |
Paid to pharmacies, not to this prescriber.
Other physical medicine and rehabilitation in Homestead
- Anthony GiuffridaFort Lauderdale$271K
- Ryan HafnerSarasota$164K
- Cassandra ListJacksonville$154K
- Marissa McCarthyTampa$94K
- Jose Medina SanchezTampa$30K
- Alan MillerFernandina Beach$26K
- Anish SoniNaples$25K
- Jose de la TorreWesley Chapel$23K
- Kaivalya DeshpandeMiami$22K
- Ryan RamsookTallahassee$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.